Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Allergodip® India - Customized Allergen Panels for the Local Market

Published: Wednesday, December 19, 2012
Last Updated: Wednesday, December 19, 2012
Bookmark and Share
Omega launches Allergodip® India EIA at the recent WISC 2012 held in Hyderabad, India.

Omega Diagnostics Group PLC has successfully launched its Allergodip® India enzyme immunoassay (EIA) at the recent World Allergy Organization International Scientific Conference (WISC 2012), held in Hyderabad, India, from the 6th to the 9th of December.

Allergodip India is an adaptation of Omega Diagnostic’s popular Allergodip assay, and offers customized allergen panels for the Indian marketplace.

This semi-quantitative EIA for the determination of Specific IgE in serum or plasma is designed to screen for the most common triggers of allergic diseases in India, and is currently available as two panels; Inhalation - India, and Food - India.

Allergodip India is an easy-to-use, simple test that generates a clear, visual result by comparison of the assay dipstick with a color chart.

No laboratory equipment is necessary, eliminating capital expenditure and the need for a service contract.

Quality of results is ensured by integrated positive and negative controls, and the assay has a diagnostic specificity of 100 % and a sensitivity of 97.5 %.

Allergodip India is supplied with ready-to-use reagents and requires minimal hands-on time, helping to reduce errors and saving time, freeing up staff for other activities.

Allergodip India was very well received at the Conference, with many delegates expressing an interest in the new product.

The recent opening of its direct subsidiary based in Mumbai in July 2012 will make this new range a key focus for Omega Diagnostics in India going forwards.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Snapshot Turns T Cell Immunology on its Head
New research may have implications for 1 diabetes sufferers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Four Gut Bacteria Decrease Asthma Risk in Infants
New research by scientists at UBC and BC Children’s Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos